Discussion about this post

User's avatar
Michael Madson's avatar

I am writing an article on a very similar topic, but arrive at some different conclusions. As far as I can tell, the problem with OxyContin was not the high dosage, although journalists have attempted that argument. The forerunner of OxyContin, MS Contin, had much higher dosages, yet it has maintained a clean record throughout the opioid crisis. In addition, Purdue Pharma discontinued the headiest form of OxyContin in attempts to counter abuse and diversion. The company also invested heavily in other efforts to combat the opioid crisis, which of course documentaries like Dopesick leave out.

Did Purdue make tragic mistakes? No question. Were they driven by profit? Of course. But the opioid crisis was not in their corporate interest, and there is much more to the story.

Stay tuned...

Feral Finster's avatar

Hell, in its day, cocaine revolutionized dentistry and eye surgery. It was the first local anesthetic.

In fact, newer anesthetics, Novocain, Harvacain, etc. are basically synthetic cocaine, designed to amplify pain-killing properties and not the euphoria.

7 more comments...

No posts

Ready for more?